Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection

Name: Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection
Published: 2015
License: Public Domain

ViiV Healthcare · 2015

ClinicalTrials.gov · Datasets · License: Public Domain · 2015

Open Source ↗

co-infection hiv-infections human-immunodeficiency-virus infection mycobacterium-tuberculosis

infection, human immunodeficiency virus, hiv infections, integrase inhibitor, mycobacterium tuberculosis, rifampicin-sensitive, dolutegravir, antiretroviral therapy-naïve, hiv-1 infection, efavirenz, co-infection, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection

Related documents